Removing, freezing, and then reimplanting ovarian tissue may delay menopause, finds study

Written By :  Dr. Shravani Dali
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-02-21 01:45 GMT   |   Update On 2024-02-21 09:55 GMT

Removing, freezing, and then reimplanting ovarian tissue may delay menopause suggests a new study published in the American Journal of Obstetrics and Gynecology.Ovarian tissue cryopreservation has been proven to preserve fertility against gonadotoxic treatments. It has not been clear how this procedure would perform if planned for slowing ovarian ageing. This study aimed to determine...

Login or Register to read the full article

Removing, freezing, and then reimplanting ovarian tissue may delay menopause suggests a new study published in the American Journal of Obstetrics and Gynecology.

Ovarian tissue cryopreservation has been proven to preserve fertility against gonadotoxic treatments. It has not been clear how this procedure would perform if planned for slowing ovarian ageing. This study aimed to determine the feasibility of cryopreserving ovarian tissue to extend the reproductive life span and delay menopause by autotransplantation near menopause. Based on the existing biological data on follicle loss rates, a stochastic model of primordial follicle wastage was developed to determine the years of delay in menopause (denoted by D) by ovarian tissue cryopreservation and transplantation near menopause. The model accounted for (1) age at ovarian tissue harvest (21–40 years), (2) the amount of ovarian cortex harvested, (3) transplantation of harvested tissues in single vs multiple procedures (fractionation), and (4) posttransplant follicle survival (40% [conservative] vs 80% [improved] vs 100% [ideal or hypothetical]). Results: The model predicted that, for most women aged <40 years, ovarian tissue cryopreservation and transplantation would result in a significant delay in menopause. The advantage is greater if the follicle loss after transplant can be minimized. As an example, the delay in menopause (D) for a woman with a median ovarian reserve who cryopreserves 25% of her ovarian cortex at the age of 25 years and for whom 40% of follicles survive after transplantation would be approximately 11.8 years, but this extends to 15.5 years if the survival is 80%. As another novel finding, spreading the same amount of tissue to repetitive transplants significantly extends the benefit. For example, for the same 25-year-old woman with a median ovarian reserve, 25% cortex removal, and 40% follicle survival, fractionating the transplants to 3 or 6 procedures would result in the corresponding delay in menopause (D) of 23 or 31 years. The same conditions (3 or 6 procedures) would delay menopause as much as 47 years if posttransplant follicle survival is improved to 80% with modern approaches. An interactive Web tool was created to test all variables and the feasibility of ovarian tissue freezing and transplantation to delay ovarian ageing (here). The model predicts that with harvesting at earlier adult ages and better transplant techniques, a significant menopause postponement and, potentially, fertile life span extension can be achieved by ovarian tissue cryopreservation and transplantation in healthy women.

Reference:

Joshua Johnson, Sean D. Lawley,John W. Emerson, Kutluk H. Modeling delay of age at natural menopause with planned tissue cryopreservation and autologous transplantation.American Journal of obstetrics and Gynecology. Published:January 04, 2024DOI:https://doi.org/10.1016/j.ajog.2023.12.037

Keywords:

Removing, freezing, and then reimplanting ovarian tissue may delay menopause, American Journal of Obstetrics and Gynecology, Joshua Johnson, Sean D. Lawley,John W. Emerson, Kutluk 

Tags:    
Article Source : American Journal of obstetrics and Gynecology

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News